Fred Hutchinson Cancer Center - The Seattle HIV Vaccine Trials Unit ( Site 0002) is a clinical research site located in Seattle, Washington, United States 98104.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Fred Hutchinson Cancer Center - The Seattle HIV Vaccine Trials Unit ( Site 0002) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Fred Hutchinson Cancer Center - The Seattle HIV Vaccine Trials Unit ( Site 0002) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Fred Hutchinson Cancer Center - The Seattle HIV Vaccine Trials Unit ( Site 0002) has 1 clinical trials on record, with 1 currently active. Their work covers Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis.
Fred Hutchinson Cancer Center - The Seattle HIV Vaccine Trials Unit ( Site 0002) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.